Skip to main content
Premium Trial:

Request an Annual Quote

Keygene Buys Illumina Analyzer and Upgrades its 454 Sequencer

NEW YORK (GenomeWeb News) - Keygene said today that it has purchased a 454 GS FLX sequencer from Roche and an Illumina Genome Analyzer.
The company upgraded to the GS FLX from a GS 20 and bought the Illumina hardware to "further develop its array of innovative DNA sequence-based applications," the company said today.
In early 2006, Keygene bought a GS 20 and a signed a co-marketing collaboration with Roche to market plant genetics applications it developed using the 454 sequencer.
The company said it will use the higher-throughput GS FLX to serve its customers' sequencing needs and to support its internal mutation screening and polymorphisms discovery applications. 
Keygene said it will use the Illumina analyzer for transcript mapping and for developing applications such as its Amplified Fragment Length Polymorphism method for whole-genome mapping.
Financial terms of the deals were not released.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.